Retrospective analysis of outcomes in patients with clear cell sarcoma of the kidney: A tertiary single-institution experience

Retrospective analysis of 41 pediatric CCSK patients in China shows 5-year survival rates of 64% (event-free) and 79% (overall), with younger age correlating with worse outcomes. Most relapses occurred at the tumor bed within 19 months, highlighting need for improved treatment protocols in developing regions.